Source comparison
CJC-1295 No DAC vs Other GH Secretagogues: Protocol Comparison
Before finalizing your research protocol, understanding how CJC-1295 no DAC compares to alternative GH-modulating compounds clarifies why pulse protocols require this specific peptide structure. CJC-1295 no DAC GHRH analog. Amplifies natural pulses ~30 minutes
This comparison does not assign a generated winner or score.
- Before finalizing your research protocol, understanding how CJC-1295 no DAC compares to alternative GH-modulating compounds clarifies why pulse protocols require this specific peptide structure.
- CJC-1295 no DAC
- GHRH analog. Amplifies natural pulses
- ~30 minutes
- 1–3x per week
- Pulsatile (mimics endogenous rhythm)
- Low. Intermittent stimulation preserves sensitivity
- CJC-1295 with DAC
- GHRH analog + albumin binding
- 6–8 days
- 1x per week
- Sustained elevation (supraphysiological)
- Moderate. Chronic receptor occupancy may reduce responsiveness
- Ipamorelin
- Ghrelin mimetic. Triggers GH release
- ~2 hours
- 1–3x daily
- Sharp pulse (no cortisol/prolactin spike)
- Low with 5-days-on/2-days-off cycling
- MK-677
- Oral ghrelin receptor agonist
- 24 hours
- 1x daily
- Sustained (non-pulsatile)
- Moderate. Daily dosing may blunt natural pulsatility over time
- Exogenous GH
- Direct hormone replacement
- Varies by formulation
- Daily or multiple daily
- Replaces endogenous production entirely
- High. Suppresses natural GH axis
- Assessment
- CJC-1295 no DAC is the only option that replicates physiological pulsatility without chronic receptor occupancy. It's the gold standard for protocols prioritizing natural GH rhythm preservation over convenience.
- The 'Assessment' column reflects our evaluation based on peptide pharmacodynamics and published endocrinology research. If your protocol requires pulsatile GH elevation. Whether for metabolic studies, body composition research, or recovery optimization. CJC-1295 no DAC remains the mechanistically appropriate choice.